Tech Company Financing Transactions
InterVenn BioSciences Funding Round
InterVenn BioSciences secured a $9.4 million financing round on 12/13/2018. Investors included Genoa Ventures, Amplify Partners and Boost VC.
Transaction Overview
Company Name
Announced On
12/13/2018
Transaction Type
Venture Equity
Amount
$9,400,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing will be used to develop the company's first product, a blood-based ovarian cancer diagnostic.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
2 Tower Pl. 5th Floor
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
InterVenn BioSciences aims to find solutions for the most challenging health problems. InterVenn's approach combines the analysis of glycoproteomics using mass spectrometry with data science and artificial intelligence to quickly identify potentially actionable and clinically relevant information for conditions including cancers, autoimmunity, fibrosis, and neurodegeneration.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 12/13/2018: Akero Therapeutics venture capital transaction
Next: 12/13/2018: WhyHotel venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs